Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Inclusion Criteria

• •1. Participants who have histological diagnosis as peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).
• •2. Participant who have measurable disease.
• •3. Participant who had previous systemic chemotherapy.
• •4. Participant who had disease progression (PD) or did not have response (complete response (CR) or partial response (PR)) in systemic chemotherapy, or relapsed or progressed after systemic chemotherapy.
• •5. Participant with Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1.
• •6. Participant with adequate renal, liver and bone marrow function.
• •7. Male and female participants ≥20 years of age at the time of informed consent.
• •8. Participants who have provided written consent to participate in the study.